Needham & Company Reiterates a 'Buy' on Cynosure (CYNO); Raising Estimates & PT Again After Strong Qtr

Needham & Company reiterates a 'Buy' on Cynosure (NASDAQ: CYNO) price target of $30.00 (from $26.00).

Analyst, Dalton Chandler, said, "CYNO is the first of our aesthetic technology companies to report results for 2Q12, but its very strong performance means
that the company likely picked up market share for the seventh consecutive quarter. We think this growth is fueled by a combination of new products and good acquisitions and we think that this trend is likely to continue for the foreseeable
future due to a strong new product pipeline."

FY12 EPS estimates raised from $0.45 to $0.64 and FY13 from $0.67 to $0.79.

For an analyst ratings summary and ratings history on Cynosure click here. For more ratings news on Cynosure click here.

Shares of Cynosure closed at $23.86 yesterday.

---

Serious News for Serious Traders! Try StreetInsider.com Premium Free!

---

You May Also Be Interested In

• Fiserv (FISV) PT Lowered to $60 at Freedom Broker
• Stantec Inc. (STN:CN) (STN) PT Lowered to Cdn$169 at Desjardins
• Sansera Engineering Ltd (SANSERA:IN) PT Raised to INR4,250 at ICICI Securities